Terumo Corporation · Class II · Cleared Nov 13, 2018
| K-number | K181369 |
| Device name | Immucise Intradermal Injection System |
| Applicant | Terumo Corporation |
| Product code | FMI |
| Device class | Class II |
| Decision date | Nov 13, 2018 |
| Decision | Substantially Equivalent |
| Regulation | 880.5570 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov